Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

PlanDefinition: PlanDefinition for Recommendation: ADA Obesity Management Recommendation 8.16

Official URL: https://fevir.net/resources/PlanDefinition/179468 Version: 2.0.0-ballot
Active as of 2024-12-19 Computable Name:
Other Identifiers: FEvIR Object Identifier: 179468, OID:2.16.840.1.113883.4.642.40.44.34.1

Usage:Evidence Communication: RecommendationPlan

Copyright/Legal: https://creativecommons.org/licenses/by-nc-sa/4.0/

8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A

Id: 179468
Url: PlanDefinition for Recommendation: ADA Obesity Management Recommendation 8.16
Version: 2.0.0-ballot
Accession ID (Computable Publishing LLC) Identifier:

179468

urn:oid:2.16.840.1.113883.4.642.40.44.34.1

Title: PlanDefinition for Recommendation: ADA Obesity Management Recommendation 8.16
Type:

system: http://terminology.hl7.org/CodeSystem/plan-definition-type

code: eca-rule

display: ECA Rule

Subject:

reference: Group/32139

type: http://hl7.org/fhir/StructureDefinition/Group

code: Bariatric Surgery Eligibility Group (ADA Recommendation 8.16)

Date: 2024-12-19 14:29:51+0000
Publisher: HL7 International / Clinical Decision Support
Description:

8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A
Use Context:
code value
evidence-communication
Jurisdiction: 001
Copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/
Related Artifacts:
Actions:

Metabolic surgery is recommended.